HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION
Hong Kong
62023074114.7
Filed on 2023-06-06
62023074114.7
Filed on 2023-06-06
USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES
US Patent 11,844,769
Filed on 2021-06-02
Filed on 2021-06-02
METHODS 0F PRODUCTION OF AUTOLOGOUS T CELLS FOR TREATMENT OF B-CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF
China
202111599342.6
Filed on 2015-02-04
202111599342.6
Filed on 2015-02-04
Fully Human Antibody Binders To Human Mesothelin For CAR-T Therapeutics Treatment
European Patent
21160649.6
Filed on 2018-01-09
21160649.6
Filed on 2018-01-09
METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
United Kingdom
14718255.4
Filed on 2014-03-13
14718255.4
Filed on 2014-03-13
METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
Germany
14718255.4
Filed on 2014-03-13
14718255.4
Filed on 2014-03-13
METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
France
14718255.4
Filed on 2014-03-13
14718255.4
Filed on 2014-03-13
Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome
US Application 18/250,816
Filed on 2023-04-27
Filed on 2023-04-27
METHODS FOR TREATING INFECTIONS
US Application 18/121,496
Filed on 2023-03-14
Filed on 2023-03-14
PLK1 POLO DOMAIN INHIBITORS AND METHOD OF TREATING CANCER
European Patent
21795110.2
Filed on 2023-04-19
21795110.2
Filed on 2023-04-19